CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Class A	Common Class B	Common Stock	Common Stock Common Class A	Common Stock Common Class B	Additional Paid-in Capital	(Accumulated Deficit)	Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2020					136,913,375	4,045,199
Beginning balance at Dec. 31, 2020	$ 644,738				$ 1,369	$ 40	$ 1,662,155	$ (1,017,037)	$ (1,789)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(21,648)							(21,648)
Compensation expense related to granting of stock awards (in shares)					291,347
Compensation expense related to granting of stock awards	2,578				$ 3		2,575
Exercise of stock options (in shares)					47,535
Exercise of stock options	15						15
Purchase of vested employee restricted stock units (in shares)					(347,607)
Purchase of vested employee restricted stock units	(1,911)				$ (3)		(1,908)
Payment of dividends on common stock	(386)						(386)
Dividend equivalents, net of forfeitures	386							386
Net Change in Accumulated Derivative Unrealized Gain (Loss)	553								553
Ending balance (in shares) at Mar. 31, 2021					136,904,650	4,045,199
Ending balance at Mar. 31, 2021	624,325				$ 1,369	$ 40	1,662,451	(1,038,299)	(1,236)
Beginning balance (in shares) at Dec. 31, 2020					136,913,375	4,045,199
Beginning balance at Dec. 31, 2020	644,738				$ 1,369	$ 40	1,662,155	(1,017,037)	(1,789)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(24,982)
Net Change in Accumulated Derivative Unrealized Gain (Loss)	929
Ending balance (in shares) at Sep. 30, 2021					137,298,864	4,045,199
Ending balance at Sep. 30, 2021	627,194				$ 1,373	$ 40	1,668,065	(1,041,424)	(860)
Beginning balance (in shares) at Mar. 31, 2021					136,904,650	4,045,199
Beginning balance at Mar. 31, 2021	624,325				$ 1,369	$ 40	1,662,451	(1,038,299)	(1,236)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	1,426							1,426
Compensation expense related to granting of stock awards (in shares)					412,243
Compensation expense related to granting of stock awards	2,445				$ 4		2,441
Exercise of stock options (in shares)					38,399
Exercise of stock options	17						17
Purchase of vested employee restricted stock units (in shares)					(20,317)
Purchase of vested employee restricted stock units	(98)						(98)
Payment of dividends on common stock	(194)						(194)
Dividend equivalents, net of forfeitures	201							201
Net Change in Accumulated Derivative Unrealized Gain (Loss)	206								206
Ending balance (in shares) at Jun. 30, 2021					137,334,975	4,045,199
Ending balance at Jun. 30, 2021	628,328				$ 1,373	$ 40	1,664,617	(1,036,672)	(1,030)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(4,761)							(4,761)
Compensation expense related to granting of stock awards (in shares)					(94,466)
Compensation expense related to granting of stock awards	3,325				$ (1)		3,326
Issuance of common stock related to the Employee Stock Purchase Plan (ESPP) (in shares)					38,782
Issuance of common stock related to the Employee Stock Purchase Plan ("ESPP")	142						142
Exercise of stock options (in shares)					28,800
Exercise of stock options	13				$ 1		12
Purchase of vested employee restricted stock units (in shares)					(9,227)
Purchase of vested employee restricted stock units	(31)						(31)
Payment of dividends on common stock	(1)						(1)
Dividend equivalents, net of forfeitures	9						9
Net Change in Accumulated Derivative Unrealized Gain (Loss)	170								170
Ending balance (in shares) at Sep. 30, 2021					137,298,864	4,045,199
Ending balance at Sep. 30, 2021	627,194				$ 1,373	$ 40	1,668,065	(1,041,424)	(860)
Beginning balance (in shares) at Dec. 31, 2021		140,060,355	4,045,199		140,060,355	4,045,199
Beginning balance at Dec. 31, 2021	652,205				$ 1,401	$ 40	1,671,195	(1,020,142)	(289)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(11,073)							(11,073)
Compensation expense related to granting of stock awards (in shares)					(59,352)
Compensation expense related to granting of stock awards	2,698				$ (1)		2,699
Issuance of common stock related to the Employee Stock Purchase Plan (ESPP) (in shares)					61,009
Issuance of common stock related to the Employee Stock Purchase Plan ("ESPP")	177				$ 1		176
Purchase of vested employee restricted stock units (in shares)					(621,876)
Purchase of vested employee restricted stock units	(1,839)				$ (6)		(1,833)
Payment of dividends on common stock	(174)						(174)
Dividend equivalents, net of forfeitures	202							202
Net Change in Accumulated Derivative Unrealized Gain (Loss)	1,223								1,223
Ending balance (in shares) at Mar. 31, 2022					139,440,136	4,045,199
Ending balance at Mar. 31, 2022	643,419				$ 1,395	$ 40	1,672,063	(1,031,013)	934
Beginning balance (in shares) at Dec. 31, 2021		140,060,355	4,045,199		140,060,355	4,045,199
Beginning balance at Dec. 31, 2021	652,205				$ 1,401	$ 40	1,671,195	(1,020,142)	(289)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	$ (152,821)
Exercise of stock options (in shares)	0
Net Change in Accumulated Derivative Unrealized Gain (Loss)	$ 3,198
Ending balance (in shares) at Sep. 30, 2022		141,322,193	4,045,199		141,322,193	4,045,199
Ending balance at Sep. 30, 2022	507,011				$ 1,413	$ 40	1,675,404	(1,172,755)	2,909
Beginning balance (in shares) at Mar. 31, 2022					139,440,136	4,045,199
Beginning balance at Mar. 31, 2022	643,419				$ 1,395	$ 40	1,672,063	(1,031,013)	934
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(773)							(773)
Compensation expense related to granting of stock awards (in shares)					1,738,025
Compensation expense related to granting of stock awards	2,481				$ 17		2,464
Issuance of common stock related to the Employee Stock Purchase Plan (ESPP) (in shares)					141,187
Issuance of common stock related to the Employee Stock Purchase Plan ("ESPP")	132				$ 1		131
Purchase of vested employee restricted stock units (in shares)					(22,814)
Purchase of vested employee restricted stock units	(51)						(51)
Payment of dividends on common stock	(4)						(4)
Dividend equivalents, net of forfeitures	4							4
Net Change in Accumulated Derivative Unrealized Gain (Loss)	553								553
Ending balance (in shares) at Jun. 30, 2022					141,296,534	4,045,199
Ending balance at Jun. 30, 2022	645,761				$ 1,413	$ 40	1,674,603	(1,031,782)	1,487
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(140,975)							(140,975)
Compensation expense related to granting of stock awards (in shares)					(168,167)
Compensation expense related to granting of stock awards	726				$ (2)		728
Issuance of common stock related to the Employee Stock Purchase Plan (ESPP) (in shares)					198,188
Issuance of common stock related to the Employee Stock Purchase Plan ("ESPP")	77			$ 2			75
Purchase of vested employee restricted stock units (in shares)					(4,362)
Purchase of vested employee restricted stock units	(2)						(2)
Payment of dividends on common stock	0						0
Dividend equivalents, net of forfeitures	2							2
Net Change in Accumulated Derivative Unrealized Gain (Loss)	1,422								1,422
Ending balance (in shares) at Sep. 30, 2022		141,322,193	4,045,199		141,322,193	4,045,199
Ending balance at Sep. 30, 2022	$ 507,011				$ 1,413	$ 40	$ 1,675,404	$ (1,172,755)	$ 2,909